Narrow-band imaging and white light imaging for non-muscle invasive bladder cancer: a meta-analysis

Yunhan Wang,Xiang Li

DOI: https://doi.org/10.19558/j.cnki.10-1020/r.2017.04.009

2017-01-01

Abstract:Objective:To systematically evaluate the value of cystoscopy by narrow-band imaging (NBI) for non-muscle-invasive bladder caner.Methods:We searched through the major medical databases such as Pub Med,EMBASE,Medline,Science Citation Index,Web of Science and Chinese National Knowledge Infrastructure Database (CNKI) and Wangfang (Database of Chinese Ministry of Science & Technology) for all published studies from 2007 until July 2016.The following search terms were used:"bladder cancer","White-Light Imaging","Narrow Band Imaging".Furthermore,additional related studies were manually searched in the reference lists of all published reviews and retrieved articles.We used the Review Manager software (RevMan 5.3,Cochrane Collaboration) to carry out the meta-analysis.Results:There were 20 eligible studies included.We found the detection rate on bladder cancer patients was significantly higher in NBI group than in WLI group (RR=1.17,[95% CI:1.11,1.23],P<0.000 01,I2=0%),and the detection rate of carcinoma in situ also was higher in NBI group than in WLI group (RR=1.47,[95% CI:1.27,1.69],P<0.000 01,I2=66%).Meanwhile,the recurrence rate of TURBT was significantly lower in NBI group than in WLI group (RR=0.67,[95% CI:0.50,0.89],P=0.006,I2=52%).Conclusions:Cystoscopy by NBI was considered to detect more patients of non-muscle-invasive bladder cancer and carcinoma in situ than WLI,and it might reduce the recurrence rate after TURBT.